CORRECTION article

Front. Cardiovasc. Med., 27 June 2025

Sec. Cardiovascular Pharmacology and Drug Discovery

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1636315

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system

  • JJ

    Jiazhen Jiang 1

  • QZ

    Qian Zhong 2

  • XZ

    Xinyu Zhou 1

  • LZ

    Lisi Zhou 3

  • JZ

    Jiyuan Zheng 1

  • BL

    Bingshuo Liu 4

  • XD

    Xingwei Di 5*

  • 1. The First Clinical Medical School of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

  • 2. Department of Cardiovascular Medicine, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China

  • 3. Clinical Medical College of Acupuncture, Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

  • 4. The Fifth Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong,China

  • 5. Department of Cardiovascular Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong,China

Article metrics

View details

1,1k

Views

313

Downloads

The order of authors in the author list of the published paper was erroneously given as: Xingwei Di, Jiazhen Jiang, Qian Zhong, Xinyu Zhou, Lisi Zhou, Jiyuan Zheng, and Bingshuo Liu. The correct author list reads: Jiazhen Jiang, Qian Zhong, Xinyu Zhou, Lisi Zhou, Jiyuan Zheng, Bingshuo Liu and Xingwei Di. The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

amlodipine, adverse drug reactions, FDA adverse event reporting system, risk signal detection, logistic regression

Citation

Jiang J, Zhong Q, Zhou X, Zhou L, Zheng J, Liu B and Di X (2025) Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system. Front. Cardiovasc. Med. 12:1636315. doi: 10.3389/fcvm.2025.1636315

Received

27 May 2025

Accepted

11 June 2025

Published

27 June 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2025

Updates

Copyright

*Correspondence: Xingwei Di

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics